A-share pharmaceutical concepts strengthened in the morning session, with concepts such as CRO, biologics, and innovative drugs rising in the short term. Kangchen Pharmaceutical hit the daily limit, Anko Biopharma rose more than 6%, and stocks such as Kangtai Biological, Zhifei Biopharma, and Ganli Pharmaceutical followed suit.